Unaudited Financial results of the Company for quarter ended June 30, 2026.
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 05 Aug 2026, 02:35 PM IST · BSE ID: a760a3c2-9cd4-41e9-9d0f-788d2892014d
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has approved its latest quarterly financial results, showing its earnings and revenue for the recent period.
🤖 AI Summary
- Board of Directors approved unaudited financial results for the quarter ended June 30, 2026.
- Revenue from operations was Rs. 876.84 million for Q1 FY27.
- Profit before tax for the quarter reached Rs. 38.87 million.
- Profit for the period stood at Rs. 31.83 million for Q1 FY27.
- Basic and diluted Earnings Per Share (EPS) reported as Rs. 0.72.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q1 FY27)
876.84 million
12.20%
Revenue from operations (Q1 FY26)
781.48 million
Profit before tax (Q1 FY27)
38.87 million
-23.74%
Profit before tax (Q1 FY26)
50.97 million
Profit for the period (Q1 FY27)
31.83 million
-20.25%
Profit for the period (Q1 FY26)
40.17 million
Earnings per equity share (Q1 FY27)
0.72
-20.88%
Earnings per equity share (Q1 FY26)
0.91
🏢 How This Affects the Company
The company's revenue from operations increased to Rs. 876.84 million in Q1 FY27 from Rs. 781.48 million in Q1 FY26, indicating continued business activity in its 'Manufacture and Sale of Chemicals' segment.
Profit before tax for the quarter was Rs. 38.87 million, a reduction from Rs. 50.97 million in the comparable prior year quarter. Total expenses increased to Rs. 872.86 million from Rs. 751.43 million year-over-year, impacting profitability.
The increase in cost of materials consumed to Rs. 578.00 million from Rs. 372.69 million in the prior year quarter suggests higher input costs or increased production volume.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as these unaudited financial results provide an update on the company's financial performance, including a reported Earnings Per Share of Rs. 0.72 for the quarter.
🔍
Management Signal
The approval and disclosure of the unaudited financial results indicate management's adherence to regulatory requirements and commitment to providing financial updates.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results — check for revenue and profit trends.
Any further disclosures regarding changes in cost of materials consumed.
Updates on the company's 'Manufacture and Sale of Chemicals' segment performance.
MEDIUM RISK
Increased expenses led to a notable decline in quarterly profitability despite revenue growth.
💡 Investor Takeaway
Link Pharma Chem Ltd reported Q1 FY27 revenue from operations of Rs. 876.84 million, an increase from Rs. 781.48 million in Q1 FY26. However, profit before tax decreased to Rs. 38.87 million from Rs. 50.97 million year-over-year, with profit for the period at Rs. 31.83 million.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from operations increased by 12.20% to Rs. 876.84 million in Q1 FY27, compared to Rs. 781.48 million in Q1 FY26.
- Other income showed significant growth, increasing to Rs. 34.89 million in Q1 FY27 from Rs. 20.92 million in Q1 FY26.
⚠️ Concerns
- Profit before tax decreased by 23.74% to Rs. 38.87 million in Q1 FY27, from Rs. 50.97 million in Q1 FY26.
- Profit for the period decreased by 20.25% to Rs. 31.83 million in Q1 FY27, compared to Rs. 40.17 million in Q1 FY26.
📅 Company Track Record
Link Pharma Chem Ltd previously reported Q1 FY27 revenue of Rs. 876.84 million and profit before tax of Rs. 38.87 million in an outcome of Board Meeting filing on August 05, 2026, confirming these figures.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Link Pharma Chem Ltd's revenue from operations for the quarter ended June 30, 2026?
Link Pharma Chem Ltd reported revenue from operations of Rs. 876.84 million for the quarter ended June 30, 2026.
What was the profit before tax for Link Pharma Chem Ltd in Q1 FY27?
The profit before tax for Link Pharma Chem Ltd for the quarter ended June 30, 2026, was Rs. 38.87 million.
How did Link Pharma Chem Ltd's profit for the period compare year-over-year for Q1?
Link Pharma Chem Ltd's profit for the period decreased to Rs. 31.83 million in Q1 FY27 from Rs. 40.17 million in Q1 FY26.
What was the Earnings per equity share (EPS) for Link Pharma Chem Ltd for Q1 FY27?
The basic and diluted Earnings per equity share (FV of Rs. 10) for Link Pharma Chem Ltd for the quarter ended June 30, 2026, was Rs. 0.72.
What were the total expenses for Link Pharma Chem Ltd in Q1 FY27?
Link Pharma Chem Ltd reported total expenses of Rs. 872.86 million for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.